Danielle Rae Behrens, LCPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 450 Chippingwood Dr, Port Republic, MD 20676 Phone: 480-335-1221 |
News Archive
Using novel transgenic mouse models they developed, Massachusetts General Hospital investigators have provided new evidence that it is the ratio of omega-6 and omega-3 fatty acids, rather than the total amount of them, that influences risk of developing chronic disease.
Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WuXi AppTec, a leading supplier of R&D services to the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, has purchased the Provantis Portal Remote Study Monitoring solution.
Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration has cleared its ingestible sensor for marketing as a medical device. The ingestible sensor (formally referred to as the Ingestion Event Marker or IEM) is part of the Proteus digital health feedback system, an integrated, end-to-end personal health management system that is designed to help improve patients' health habits and connections to caregivers.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. The new data are from one of the longest, continuously-dosed, placebo-controlled trials of a sleep medication ever conducted.
The Food and Drug Administration recently announced a change to current dosages for sleeping medications in women to half the current prescribed level, and research suggests that flu dosages for women be reconsidered as well. Consideration of how women respond to medicine should be common practice, but we aren't there yet.
› Verified 8 days ago